newsfilter
← Latest News
GlobeNewswire·

Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

  • Aquestive Therapeutics, Inc. announced its management team will participate in the virtual Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026.
  • The company's presentation is scheduled for February 26 at 12 pm ET, with one-on-one investor meetings also occurring that day.
  • A webcast of the presentation will be available under the "Events and Presentations" section of investors.aquestive.com, with a replay accessible for 30 days post-event.
  • Aquestive operates as a pharmaceutical developer \& Contract Development and Manufacturing Organization (CDMO) with headquarters in New Jersey \& manufacturing facilities in Indiana.
  • The company is the exclusive manufacturer of four commercialized products across six continents using its PharmFilm® technology.
  • Aquestive's AdrenaVerse™ platform includes a library of over 20 epinephrine prodrugs targeting allergy \& dermatological indications.
  • The company is advancing Anaphylm™ sublingual film for severe allergic reactions \& AQST-108 topical gel for conditions such as alopecia areata.
  • The press release contains forward-looking statements subject to risks including development delays, cost changes, \& clinical trial outcomes.